Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A Levels
暂无分享,去创建一个
B. Mahajan | A. Mane | A. Risbud | R. Desai | Neeta Bagul | A. Shete | Mamatha G. S. Reddy | Amit Mahajan
[1] M. Jabra-Rizk,et al. Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals. , 2013, Journal of AIDS & clinical research.
[2] M. Moriyama,et al. Close association between oral Candida species and oral mucosal disorders in patients with xerostomia. , 2012, Oral diseases.
[3] S. Chambers,et al. Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus. , 2011, Medical mycology.
[4] A. Mane,et al. Adherence to buccal epithelial cells, enzymatic and hemolytic activities of Candida isolates from HIV-infected individuals. , 2010, Medical mycology.
[5] G. Proctor,et al. A Comparative Study of Salivary Composition of HIV Seropositive Patients on HAART and Not on HAART , 2011 .
[6] S. Bembalkar,et al. Species distribution & antifungal susceptibility of oral Candida colonising or infecting HIV infected individuals. , 2010, The Indian journal of medical research.
[7] S. Talungchit,et al. Effects of long-term use of HAART on oral health status of HIV-infected subjects. , 2010, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[8] K. Stoltze,et al. Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era. , 2010, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[9] J. Selvin,et al. Phospholipase C, proteinase and hemolytic activities of Candida spp. isolated from pulmonary tuberculosis patients , 2009 .
[10] W. Mack,et al. Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS). , 2009, Oral diseases.
[11] N. Cerikcioglu,et al. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures , 2007, Mycopathologia.
[12] L. K. H. Souza,et al. Asymptomatic oral carriage of Candida species in HIV-infected patients in the highly active antiretroviral therapy era. , 2006, Revista do Instituto de Medicina Tropical de Sao Paulo.
[13] Dorthea A. Johnson,et al. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART). , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[14] J. Belforte,et al. Standardization of a simple method to study whole saliva: clinical use in different pathologies. , 2006, Acta odontologica latinoamericana : AOL.
[15] L. McDonald,et al. Colonization of Human Immunodeficiency Virus-Infected Outpatients in Taiwan with Candida Species , 2005, Journal of Clinical Microbiology.
[16] D. Kotler,et al. Intestinal plasma cell alterations in acquired immunodeficiency syndrome , 1987, Digestive Diseases and Sciences.
[17] Donald R. Miller,et al. Xerostomic medications and oral health: the Veterans Dental Study (part I). , 2003, Gerodontology.
[18] R. Mulligan,et al. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[19] A. Fleva,et al. Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects , 2002, International journal of STD & AIDS.
[20] R. Swoboda,et al. A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis. , 2002, The Journal of infectious diseases.
[21] M. Nucci,et al. Relationship between salivary flow rates and Candida counts in subjects with xerostomia. , 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[22] E. Komaroff,et al. The Prevalence of Xerostomia and Salivary Gland Hypofunction in a Cohort of HIV-positive and At-risk Women , 2000, Journal of dental research.
[23] M. Rinaldi,et al. Further Characterization of Human Salivary Anticandidal Activities in a Human Immunodeficiency Virus-Positive Cohort by Use of Microassays , 1999, Clinical Diagnostic Laboratory Immunology.
[24] D. Rahman,et al. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. , 1995, Immunology.
[25] S. Michalek,et al. Advances in Mucosal Immunology , 1995, Advances in Experimental Medicine and Biology.
[26] C. Barr,et al. Longitudinal study of parotid saliva in HIV-1 infection. , 1992, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[27] J. Koval,et al. Factors associated with increased frequency of HIV-related oral candidiasis. , 1991, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[28] S. Frøland,et al. Both IgA subclasses are reduced in parotid saliva from patients with AIDS , 1991, Clinical and experimental immunology.
[29] T. Soukka,et al. Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry. , 1991, Proceedings of the Finnish Dental Society. Suomen Hammaslaakariseuran toimituksia.
[30] S. Jackson. Secretory and serum IgA are inversely altered in AIDS patients , 1990 .